TGFB1 and colorectal carcinoma: Furthermore, hypermethylation of TGF-β pathway inhibitors may exacerbate signaling, contributing to the epithelial-mesenchymal transition and metastatic potential of CRC cells.169 Modulation of DNA methylation patterns in these key nodes of TGF-β signaling may offer a therapeutic lever to mitigate CRC progression.